Bristol Myers Squibb Co. (BMY)
57.58
-0.36
(-0.62%)
USD |
NYSE |
Jul 10, 16:00
57.50
-0.08
(-0.14%)
After-Hours: 20:00
Bristol Myers Squibb Total Return Level : 217.85 for July 10, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| July 10, 2026 | 217.85 |
| July 09, 2026 | 219.21 |
| July 08, 2026 | 217.70 |
| July 07, 2026 | 219.32 |
| July 06, 2026 | 214.52 |
| July 02, 2026 | 219.93 |
| July 01, 2026 | 211.25 |
| June 30, 2026 | 215.66 |
| June 29, 2026 | 219.18 |
| June 26, 2026 | 215.29 |
| June 25, 2026 | 207.32 |
| June 24, 2026 | 205.86 |
| June 23, 2026 | 207.84 |
| June 22, 2026 | 204.73 |
| June 18, 2026 | 202.11 |
| June 17, 2026 | 206.90 |
| June 16, 2026 | 209.30 |
| June 15, 2026 | 210.50 |
| June 12, 2026 | 213.83 |
| June 11, 2026 | 212.97 |
| June 10, 2026 | 208.10 |
| June 09, 2026 | 211.40 |
| June 08, 2026 | 207.99 |
| June 05, 2026 | 214.35 |
| June 04, 2026 | 211.85 |
| Date | Value |
|---|---|
| June 03, 2026 | 204.81 |
| June 02, 2026 | 203.84 |
| June 01, 2026 | 205.67 |
| May 29, 2026 | 214.02 |
| May 28, 2026 | 213.01 |
| May 27, 2026 | 215.29 |
| May 26, 2026 | 217.20 |
| May 22, 2026 | 222.55 |
| May 21, 2026 | 222.89 |
| May 20, 2026 | 219.11 |
| May 19, 2026 | 218.25 |
| May 18, 2026 | 214.50 |
| May 15, 2026 | 213.34 |
| May 14, 2026 | 212.48 |
| May 13, 2026 | 211.06 |
| May 12, 2026 | 211.28 |
| May 11, 2026 | 208.36 |
| May 08, 2026 | 210.20 |
| May 07, 2026 | 210.54 |
| May 06, 2026 | 211.81 |
| May 05, 2026 | 213.16 |
| May 04, 2026 | 214.76 |
| May 01, 2026 | 217.91 |
| April 30, 2026 | 226.78 |
| April 29, 2026 | 215.55 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Johnson & Johnson | 610.21 |
| Eli Lilly & Co. | 3135.88 |
| Merck & Co., Inc. | 379.79 |
| Pfizer Inc. | 79.46 |
| AstraZeneca PLC | 430.31 |